(+/-)-7-(4-amino-3-hydroxybutyloxy)-2H-1-benzopyran-2-one | 326595-99-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: (+/-)-7-(4-amino-3-hydroxybutyloxy)-2H-1-benzopyran-2-one
• 英文别名: 1-amino-4-(7-coumarinyloxy)-2-butanol；7-(4-amino-3-hydroxybutoxy)chromen-2-one
• CAS: 326595-99-7
• 化学式: C₁₃H₁₅NO₄
• 分子量: 249.266
• InChiKey: SLRNCTMYJRIBPI-UHFFFAOYSA-N

物化性质

• 沸点：
  488.6±45.0 °C(Predicted)
• 密度：
  1.297±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  81.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (+/-)-7-(4-amino-3-hydroxybutyloxy)-2H-1-benzopyran-2-one 在 bovine serum albumin sodium periodate 、 borate buffer 作用下， 生成 7-羟基香豆素
  参考文献：
  名称：

  Badalassi, Fabrizio; Wahler, Denis; Klein, Gerald, Angewandte Chemie - International Edition, 2000, vol. 39, # 22, p. 4067 - 4070

  摘要：

  DOI：
• 作为产物：
  描述：

  (+/-)-7-(3,4-epoxybutyloxy)-2H-1-benzopyran-2-one 在 ammonium hydroxide 作用下， 生成 (+/-)-7-(4-amino-3-hydroxybutyloxy)-2H-1-benzopyran-2-one
  参考文献：
  名称：

  Badalassi, Fabrizio; Wahler, Denis; Klein, Gerald, Angewandte Chemie - International Edition, 2000, vol. 39, # 22, p. 4067 - 4070

  摘要：

  DOI：

文献信息

• Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof
  申请人：Proteus

  公开号：US20030199017A1

  公开（公告）日：2003-10-23

  This invention has as its object a method for releasing a product by subjecting a compound of Formula (II′): R′ 7 R′ 8 (HX)C 1 -C 2 (YH)R′ 9 R′ 10 to a chemical oxidation that cleaves the bond C 1 -C 2 to obtain the product. In the compound of Formula (II′): R′ 7 to R′ 10 , which are identical or different, correspond to a hydrogen atom, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted functional group; X and Y, which are identical or different, are an oxygen atom, a sulfur atom, or an amine of Formula -NR 11 R 12 , wherein R 11 is a hydrogen atom, an alkyl group, or a substituted or unsubstituted aryl group, and R 12 is not a hydrogen atom. The invention also has as its object a method for releasing a product that comprises, before the chemical oxidation stage, a first step for preparing the compound of Formula (II′). The released product can be a volatile molecule or an active substance or else a specific product. The invention also relates to a method for detecting the released product as well as its applications, in particular for detecting catalytic or enzymatic activities.

  本发明的目的是通过将式（II'）的化合物进行化学氧化裂解C1-C2键来释放产品。在式（II'）的化合物中，R'7到R'10表示氢原子，取代或未取代的烷基或取代或未取代的功能基团，其中R'7到R'10可以相同也可以不同；X和Y表示氧原子、硫原子或式-NR11R12的胺，其中R11表示氢原子、烷基或取代或未取代的芳基，而R12不是氢原子。本发明还涉及在化学氧化阶段之前，通过第一步制备式（II'）的化合物的方法来释放产品。释放的产品可以是挥发性分子、活性物质或特定产品。本发明还涉及一种检测释放产品的方法及其应用，特别是用于检测催化或酶活性。
• Substituted anilinic piperidines as MCH selective antagonists
  申请人：Marzabadi R. Mohammad

  公开号：US20070043080A1

  公开（公告）日：2007-02-22

  This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

  本发明涉及选择性拮抗黑色素浓集激素-1（MCH1）受体的化合物。本发明提供了一种药物组合物，包括本发明化合物的治疗有效量和药学上可接受的载体。本发明提供了一种由本发明化合物的治疗有效量和药学上可接受的载体组成的药物组合物。本发明还提供了一种制备药物组合物的方法，包括将本发明化合物的治疗有效量和药学上可接受的载体组合。
• Non-hydrolytic microbial probes
  申请人：Biosynth AG

  公开号：EP2184367A1

  公开（公告）日：2010-05-12

  A method of detecting the presence of selected living cells in a sample, comprises the steps of contacting the sample with a substrate compound and monitoring for a signal caused by a metabolic activity of said selected living cells resulting in a release of a signalogenic moiety from the substrate compound. The substrate compound has the formula wherein X is O or NH, A is H or a first enzymatically hydrolyzable group, B is R3 or CH-Y-D, wherein Y is O or NH and D is H or a second enzymatically hydrolyzable group, R1, R2 and R3 are independently selected inert groups, and Sig-O is a signalogenic moiety that upon release thereof converts to said signalophore.

  一种检测样品中是否存在选定活细胞的方法，包括以下步骤：将样品与一种底物化合物接触，并监测由所述选定活细胞的代谢活动导致底物化合物释放信号分子而产生的信号。底物化合物的分子式为 其中 X 是 O 或 NH，A 是 H 或第一可酶水解基团，B 是 R3 或 CH-Y-D，其中 Y 是 O 或 NH，D 是 H 或第二可酶水解基团，R1、R2 和 R3 是独立选择的惰性基团，Sig-O 是信号原分子，释放后转化为所述信号团。
• Enzyme Fingerprints of Activity, and Stereo- and Enantioselectivity from Fluorogenic and Chromogenic Substrate Arrays
  作者：Denis Wahler、Fabrizio Badalassi、Paolo Crotti、Jean-Louis Reymond

  DOI：10.1002/1521-3765(20020715)8:14<3211::aid-chem3211>3.0.co;2-g

  日期：2002.7.15

  A series of stereochemically and structurally diverse fluorogenic and chromogenic substrates for hydrolytic enzymes has been synthesized and used to characterize enzyme activity profiles of esterases, lipases, proteases, peptidases, phosphatases, and epoxide hydrolases. The substrates used are particularly resilient to nonspecific reactions due to their mechanism of activation. The activities recorded with the individual substrates are therefore remarkably reproducible, and enable us to use the overall pattern of activity as a specific fingerprint for the enzyme sample. Fingerprints of activity, and enantio- and stereoselectivity are displayed as arrays of color-scale squares that are easily analyzed visually. Such fingerprints might be useful for quality control, enzyme discovery, and possibly for addressing the issue of functional convergence in enzymes.
• METHODE OXYDANTE DE LIBERATION D'UN PRODUIT DETECTABLE
  申请人：Proteus

  公开号：EP1285086A2

  公开（公告）日：2003-02-26